GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Silco Pharmaceuticals Ltd (DHA:SILCOPHL) » Definitions » Net Income (Continuing Operations)

Silco Pharmaceuticals (DHA:SILCOPHL) Net Income (Continuing Operations) : BDT0.00 Mil (TTM As of . 20)


View and export this data going back to 2019. Start your Free Trial

What is Silco Pharmaceuticals Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Silco Pharmaceuticals's Net Income (Continuing Operations) for the six months ended in . 20 was BDT0.00 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in . 20 was BDT0.00 Mil.

Silco Pharmaceuticals Net Income (Continuing Operations) Historical Data

The historical data trend for Silco Pharmaceuticals's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Silco Pharmaceuticals Net Income (Continuing Operations) Chart

Silco Pharmaceuticals Annual Data
Trend
Net Income (Continuing Operations)

Silco Pharmaceuticals Semi-Annual Data
Net Income (Continuing Operations)

Silco Pharmaceuticals Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in . 20 was BDT0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Silco Pharmaceuticals  (DHA:SILCOPHL) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Silco Pharmaceuticals Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Silco Pharmaceuticals's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Silco Pharmaceuticals (DHA:SILCOPHL) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Silco Pharmaceuticals Ltd (DHA:SILCOPHL) » Definitions » Net Income (Continuing Operations)
Comparable Companies
Traded in Other Exchanges
N/A
Address
41, Nurani, Bankolapara, Subidbazar, Sylhet, BGD, 3100
Website
http://www.silcopharma.com
Silco Pharmaceuticals Ltd is engaged in manufacturing and marketing of pharmaceuticals finished products in the categories of Antibiotics, Analgesics, Anti diabetics, Narcotics, Antipyratics, Anti-inflammatory Drugs, Antiulcerants, Multi medicines which are sold mainly in local market.

Silco Pharmaceuticals (DHA:SILCOPHL) Headlines

No Headlines